Article by David Brown, Lift
Health Canada announced today that on March 8, 2017, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary recall of one lot of dried marijuana under a Type III recall. One lot (652-4883) of cannabis was mislabelled as containing 22.3% THC instead of 21.1% THC.
A Type III recall refers to “a situation in which the use of, or exposure to a product, is not likely to cause any adverse health consequences.”
Health Canada says they have not received any adverse reaction reports for products sold by Aphria. Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aphria at the following number: 1-844-427-4742.
Aphria released this statement to Lift today: “On March 8, 2017, Aphria identified 20 patient orders in which the label incorrectly identified the actual THC content. As a result, Aphria issued a voluntary recall and all but one order has been returned. The variance is not likely to cause any adverse health consequences. Aphria has identified the source of the labelling issue and has implemented measures to prevent reoccurrence.”
Official link here.
Health Canada lists their three recall types as such
- Type I: a situation in which there is a reasonable probability that the use of, or exposure to, a product will cause serious adverse health consequences or death,
- Type II: a situation in which the use of, or exposure to, a product may cause temporary adverse health consequences or where the probability of serious adverse health consequences is remote, or
- Type III: a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.